Navigation Links
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Date:7/15/2009

Background on Gaucher disease

Gaucher disease is an autosomal recessive disease and the most prevalent Lysosomal Storage Disorder (LSD), with an incidence of about 1 in 20,000 live births. Despite the fact that Gaucher Disease consists of a phenotype, with varying degrees of severity, it has been sub-divided in three subtypes according to the presence or absence of neurological involvement. It is also the most common genetic disease affecting Ashkenazi Jewish people (Eastern, Central and Northern European ancestry), with a carrier frequency of 1 in 10 (Dr. John Barranger and Dr. Ed Ginns 1989). This panethnic disease involves many organ systems, such as liver, spleen, lungs, brain, metabolism and bone marrow.

Gaucher Disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. The disease course is quite variable, ranging from no outward symptoms to severe disability and death. Carrier status can be detected through blood or saliva to identify potential carriers of the Gaucher gene. Gaucher Disease can be diagnosed early through a blood test.

Worldwide the diagnosed population of Gaucher Disease patients is approximately 7,000. Based on incidence, the estimated total world population is likely to be between 10,000 and 15,000 patients.

Notes to Editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
2. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
3. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
4. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
5. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
6. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
7. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
8. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
9. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
10. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
11. USC Keck School of Medicines Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Amgen (NASDAQ: AMGN ) will present at the ... ET on Thursday, April 2, 2015, at the Goldman Sachs ... Scott Foraker , vice president and general manager of ... of the presentation can be accessed from the Events Calendar ... of the webcast will also be available on Amgen,s website ...
(Date:3/30/2015)... MORGANTOWN, W. Va. , March 30, 2015 ... (BRNI) and the Marshall University Joan C. Edwards ... new study entitled, "PSEN1 Variant in a Family ... severe disease, genetically confirmed to have a known ... with the drug Bryostatin 1. Genetically confirmed Alzheimer,s ...
(Date:3/30/2015)... 2015 News Highlights: , ... at the 2015 @NatHurricaneCon , .@TheAACE and @LillyDiabetes ... manage your #diabetes before emergencies strike ... educational and scientific arm of the American Association of ... Diabetes to share the My Diabetes Emergency Plan ...
Breaking Medicine Technology:Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 4Severe Alzheimer's Patient Responds to Bryostatin Treatment 5Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4
... SOUTH SAN FRANCISCO, Calif., May 6 Exelixis,Inc. ... for the first quarter,ended March 31, 2008., ... were $27.9 million,compared to $28.1 million for the ... consistent with 2007, but reflect the completion of,revenue ...
... DIEGO, May 6 TriLink BioTechnologies (TriLink), ... has been awarded a,Phase II Small Business ... continue its investigation of modified dNTPs to ... studies demonstrated that TriLink,s,unique dNTP modifications enhanced ...
Cached Medicine Technology:Exelixis Announces First Quarter 2008 Financial Results 2Exelixis Announces First Quarter 2008 Financial Results 3Exelixis Announces First Quarter 2008 Financial Results 4Exelixis Announces First Quarter 2008 Financial Results 5Exelixis Announces First Quarter 2008 Financial Results 6TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project 2
(Date:3/30/2015)... 2015 Join local United Methodists as ... to raise funds to provide healthcare for the 512 ... will take place on Saturday, April 18, at 9 ... on 86 Vaughn Road in Nashville. , Raise the ... area without reliable medical care. The nearest clinic is ...
(Date:3/30/2015)... 2015 The pharmaceutical business has a ... manufacturing plants. This is primarily due to the decade-long ... has forced facilities to produce and perform well beyond ... have been forced to expand production, change product portfolios ... , Most of these facilities have remained in a ...
(Date:3/30/2015)... 2015 With the summer dry season ... are scrambling to make sure they have enough water. ... be aware that when Earth loses water and becomes ... become dehydrated. Kleyne calls this “body drought” and suggests ... about weather, body drought and dehydration on her Sharon ...
(Date:3/30/2015)... 30, 2015 Dr. Jeff Farmer now offers ... The mini implant is placed into the bone, usually without ... fitted and snapped into place. For those having trouble with ... could be the solution. Thousands of patients around the world ... any adhesives. It is all made possible by mini dental ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Wimbledon Health ... vascular, echocardiogram and NCV testing, ... affiliated physicians in observance of National Doctor’s Day. ... around our office, but on this day, we like ... important role they play in healing patients, promoting overall ...
Breaking Medicine News(10 mins):Health News:Hike2Heal and Rethink Church Raise Funds To Provide Healthcare for Ugandan Children with 3rd Annual Raise the Roof 5K on April 18 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 2Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 3Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Wimbledon Health Partners Recognizes National Doctors’ Day 2
... involved in the HIV/AIDS campaign plan to hold a ... to protest the government's Drug Policy which is seen ... ,The organisers will be delivering a petition to ... that will limit affordable AIDS medications worldwide., ,"At ...
... often respond differently to diseases and drugs probably because of ... and females//. ,Mice, which share 99 percent of ... of the study of gene activity in its brain, fat, ... been published in August issue of the journal Genome Research. ...
... Britain’s oldest mother after undergoing IVF treatment//. ... Patricia Rashbrook, gave birth to a boy, weighing about ... Hospital in Brighton, by caesarean on Wednesday. It was ... grown-up children from a previous marriage, had considered In-vitro ...
... published in the journal, Human Mutations, claims that researchers ... induced hearing loss (NIHL). Researchers at the University of ... recycling could be implicated. ,The study led by ... study of 1,000 men who were exposed to high ...
... One-year-old James Hynes, from Dundrod, UK has undergone what ... Germany//.,Doctors told his parents earlier in the year that ... public campaign, the NHS agreed to fund the surgery. ... and he agreed to perform the surgery privately.,The Eastern ...
... legislation to regulate doctors, due to be published within the ... in order to publish heads of bill for new legislation ... Medical Practitioners Bill can be published later this year. ... promised and postponed for many years, it is finally expected ...
Cached Medicine News:
... portable, digital A-scan system which provides easy-to-use ... high frequency, low noise probe and fast ... application of the probe along the visual ... display, storage of 5 different user profiles, ...
... A-Scan offers so many features ... Besides,its compact and lightweight console, ... and easy operation.,Furthermore, it has ... manual gate.,NIDEK is proud of ...
... Artemis is the world's first very high ... 3D Arc-scanning technology, Artemis provides microscopic resolution ... cornea and anterior segments of the human ... (VHF) ultrasound eye scanner. In use, the ...
ISYSTEM-ABDv2™A/B Scan unit. True Geometry With Stepped Zoom, Pan, Freeze Frame, Post Image Processing....
Medicine Products: